Tyrosine Kinase


Receptor tyrosine kinases bind to extracellular ligands/growth factors, which promotes receptor dimerization and autophosphorylation of receptor tyrosine residues. This triggers a cascade of downstream events through phosphorylation of intracellular proteins that ultimately transduce the extracellular signal to the nucleus, causing changes in gene expression. Receptor tyrosine kinases include EGFR/ErbB, PDGFR, VEGFR, FGFR and MET subfamilies etc. Dysfunctions in tyrosine phosphorylation are linked to oncogenic transformation. In additions, various adaptor and effector proteins couple to carboxy-terminal of an active kinase. For instance, binding of the GRB2 adaptor protein activates EGFR and MAPK/ERK signaling.
Non-receptor tyrosine kinases involve many well-defined proteins (e.g. the Src family kinases, c-Abl, and Jak kinases) and other kinases which regulates cell growth and differentiation. For example, Src family kinases are curial for activating and inhibitory pathways in the innate immune response.
-
C8790 Treprostinil sodiumSummary: Treprostinil sodium is a synthetic prostacyclin analog and DP1/IP/EP2 prostanoid receptor agonist used for cardiovascular, inflammation, and cAMP signaling research. -
C8799 Ensartinib (X-396) dihydrochlorideSummary: Ensartinib (X-396) dihydrochloride is a potent small-molecule dual ALK/MET kinase inhibitor used in oncology and signal transduction research. -
B8571 AlmonertinibSummary: An orally active, highly selective, third-generation irreversible tyrosine kinase inhibitor targeting mutant EGFR. -
BA6355 KhellinSummary: A natural furochromone epidermal growth factor receptor (EGFR) inhibitor. -
C9085 UNC2025 HClSummary: An ATP-competitive MERTK/FLT3 inhibitor suitable for in vitro and in vivo mechanistic studies.
